In addition to PIM1, miR-33a has been also shown to directly target a variety of genes associated with cancer progression including several genes associated with cell cycle regulation such as CDK6 (cyclin-dependent kinase 6) and CCND1 (cyclin D1), which are directly targeted by miR-33a [23]. The gene discussed is CCND1; the disease is cancer.